Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

PubWeight™: 30.07‹?› | Rank: Top 0.01% | All-Time Top 10000

🔗 View Article (PMC 4418670)

Published in Circulation on December 15, 2010

Authors

Véronique L Roger, Alan S Go, Donald M Lloyd-Jones, Robert J Adams, Jarett D Berry, Todd M Brown, Mercedes R Carnethon, Shifan Dai, Giovanni de Simone, Earl S Ford, Caroline S Fox, Heather J Fullerton, Cathleen Gillespie, Kurt J Greenlund, Susan M Hailpern, John A Heit, P Michael Ho, Virginia J Howard, Brett M Kissela, Steven J Kittner, Daniel T Lackland, Judith H Lichtman, Lynda D Lisabeth, Diane M Makuc, Gregory M Marcus, Ariane Marelli, David B Matchar, Mary M McDermott, James B Meigs, Claudia S Moy, Dariush Mozaffarian, Michael E Mussolino, Graham Nichol, Nina P Paynter, Wayne D Rosamond, Paul D Sorlie, Randall S Stafford, Tanya N Turan, Melanie B Turner, Nathan D Wong, Judith Wylie-Rosett, American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Associated clinical trials:

Efficacy Evaluation of the HEART Pathway in Emergency Department Patients With Acute Chest Pain (HEART Pathway) | NCT01665521

HEART Pathway Implementation | NCT02056964

Effects of Respiratory Training on Respiratory and Functional Performance in Patients With Stroke | NCT02726685

PARA-HEART Pilot Implementation (PARA-HEART) | NCT02709135

Flax Muffins and Cholesterol Lowering | NCT01821131

Contralaterally Controlled FES of Arm & Hand for Subacute Stroke Rehabilitation | NCT01688856

Menopause Effects on Vascular Function | NCT03236545

Effectiveness of Non-pharmacological Interventions in Patients With Cardiovascular Risk Factors in Primary Care | NCT03452709

Safety and Accuracy of the Saranas EBBMS for the Detection of Endovascular Procedure Related Bleeding Events | NCT03621202

Articles citing this

(truncated to the top 100)

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98

Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA (2011) 4.75

Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation (2012) 4.56

Incidence of treated cardiac arrest in hospitalized patients in the United States. Crit Care Med (2011) 4.43

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature (2012) 4.04

Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell (2012) 3.66

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 3.63

ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged. Neurology (2015) 3.42

Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol (2012) 2.98

Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation (2012) 2.95

Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89

Burden of Comorbidities and Functional and Cognitive Impairments in Elderly Patients at the Initial Diagnosis of Heart Failure and Their Impact on Total Mortality: The Cardiovascular Health Study. JACC Heart Fail (2015) 2.84

Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation (2012) 2.83

Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis. Gastroenterology (2013) 2.82

Elevated circulating fibrocyte levels in patients with hypertensive heart disease. J Hypertens (2012) 2.79

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74

Cognitive impairment in older adults with heart failure: prevalence, documentation, and impact on outcomes. Am J Med (2013) 2.56

Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med (2013) 2.55

Cadmium exposure and incident cardiovascular disease. Epidemiology (2013) 2.55

SCCT guidelines on radiation dose and dose-optimization strategies in cardiovascular CT. J Cardiovasc Comput Tomogr (2011) 2.52

Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women. JAMA (2011) 2.34

Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors. Radiat Environ Biophys (2012) 2.31

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J (2012) 2.30

Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull (2011) 2.26

The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18

Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet (2012) 2.17

Community Outreach and Cardiovascular Health (COACH) Trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Circ Cardiovasc Qual Outcomes (2011) 2.12

Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature (2013) 2.08

TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med (2014) 2.07

Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann Intern Med (2011) 2.06

Sex and ageing differences in resting arterial pressure regulation: the role of the β-adrenergic receptors. J Physiol (2011) 2.00

Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med (2012) 1.98

Derivation of a cardiac arrest prediction model using ward vital signs*. Crit Care Med (2012) 1.96

Primary outcomes for resuscitation science studies: a consensus statement from the American Heart Association. Circulation (2011) 1.93

C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart. Circulation (2012) 1.90

MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death. J Clin Invest (2012) 1.90

Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation (2011) 1.88

What is the evidence for physical therapy poststroke? A systematic review and meta-analysis. PLoS One (2014) 1.87

Role of vascular oxidative stress in obesity and metabolic syndrome. Diabetes (2014) 1.85

Anti-inflammatory and antiatherogenic role of BMP receptor II in endothelial cells. Arterioscler Thromb Vasc Biol (2013) 1.78

Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov (2011) 1.78

Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol (2014) 1.76

Health cobenefits and transportation-related reductions in greenhouse gas emissions in the San Francisco Bay area. Am J Public Health (2013) 1.73

Fibroblast growth factor 10 gene regulation in the second heart field by Tbx1, Nkx2-5, and Islet1 reveals a genetic switch for down-regulation in the myocardium. Proc Natl Acad Sci U S A (2012) 1.73

The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge. Circ Cardiovasc Qual Outcomes (2015) 1.72

Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol (2012) 1.72

Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J (2012) 1.71

Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem (2013) 1.71

Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes. J Mol Cell Cardiol (2013) 1.70

The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med (2013) 1.70

Can exercise teach us how to treat heart disease? Circulation (2012) 1.70

Stroke research at a crossroad: asking the brain for directions. Nat Neurosci (2011) 1.68

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68

Risk factors for hospital admission among older persons with newly diagnosed heart failure: findings from the Cardiovascular Health Study. J Am Coll Cardiol (2013) 1.67

Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence. JACC Cardiovasc Imaging (2012) 1.66

New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66

(n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J Nutr (2012) 1.64

Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes. Eur Heart J (2012) 1.64

Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J Clin Invest (2012) 1.63

Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res (2012) 1.63

Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial. Circ Heart Fail (2012) 1.62

Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J (2015) 1.62

Depressive symptoms are related to progression of coronary calcium in midlife women: the Study of Women's Health Across the Nation (SWAN) Heart Study. Am Heart J (2011) 1.61

Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ Res (2012) 1.61

Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol (2012) 1.61

"I'm not just a heart, I'm a whole person here": a qualitative study to improve sexual outcomes in women with myocardial infarction. J Am Heart Assoc (2013) 1.60

Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy. Hypertension (2012) 1.60

Prevalence of hypertension in china: a cross-sectional study. PLoS One (2013) 1.60

Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults. J Am Geriatr Soc (2012) 1.58

Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure. Circ Arrhythm Electrophysiol (2011) 1.56

Expansion of invasive cardiac services in the United States. Circulation (2013) 1.54

Acute coronary events. Circulation (2012) 1.54

Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities study. Hypertension (2012) 1.54

Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the Cardiovascular Health Study. J Am Coll Cardiol (2013) 1.53

Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study. Circ Cardiovasc Genet (2012) 1.52

FRS2α-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy activity. Circ Res (2011) 1.52

A randomized controlled trial of positive-affect induction to promote physical activity after percutaneous coronary intervention. Arch Intern Med (2012) 1.52

Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev (2013) 1.52

Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey. Heart Rhythm (2012) 1.49

Patterns of stress testing and diagnostic catheterization after coronary stenting in 250 350 medicare beneficiaries. Circ Cardiovasc Imaging (2012) 1.49

Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol (2011) 1.48

Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice. Blood (2012) 1.48

Dose-dependent increases in flow-mediated dilation following acute cocoa ingestion in healthy older adults. J Appl Physiol (1985) (2011) 1.47

Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection. Ann Thorac Surg (2011) 1.47

Myocardial infarction and intramyocardial injection models in swine. Nat Protoc (2012) 1.47

Resistant hypertension: incidence, prevalence, and prognosis. Circulation (2012) 1.46

Recent trends in cost-related medication nonadherence among stroke survivors in the United States. Ann Neurol (2013) 1.46

Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension (2012) 1.46

Mitochondria and cardiovascular aging. Circ Res (2012) 1.46

Work stress, sleep deficiency, and predicted 10-year cardiometabolic risk in a female patient care worker population. Am J Ind Med (2014) 1.45

Thirty-day rehospitalizations after acute myocardial infarction: a cohort study. Ann Intern Med (2012) 1.45

Plasma free fatty acids and risk of stroke in the Cardiovascular Health Study. Int J Stroke (2014) 1.45

Impact of advanced healthcare directives on treatment decisions by physicians in patients with acute stroke. Crit Care Med (2013) 1.44

Articles cited by this

(truncated to the top 100)

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78

Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19

Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12

Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98

Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA (1995) 38.40

Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc (2008) 38.10

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation (2009) 35.24

Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 33.23

Diagnosis and classification of diabetes mellitus. Diabetes Care (2010) 28.34

General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 25.44

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA (2001) 24.12

Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA (2010) 23.45

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23

Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17

Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36

Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34

Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 18.32

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13

Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med (1999) 16.30

The incidence of congenital heart disease. J Am Coll Cardiol (2002) 16.13

High body mass index for age among US children and adolescents, 2003-2006. JAMA (2008) 16.00

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation (2003) 15.79

Economic costs of diabetes in the U.S. In 2007. Diabetes Care (2008) 15.73

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg (2007) 14.17

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA (2010) 13.94

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79

Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65

Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep (2008) 13.54

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation (2006) 13.21

Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr (2006) 13.19

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet (1999) 13.19

Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) (2009) 12.45

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44

Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA (2008) 12.28

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care (2006) 12.14

The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation (2006) 11.78

Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension (2006) 11.68

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation (2006) 11.65

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2007) 11.64

The spread of the obesity epidemic in the United States, 1991-1998. JAMA (1999) 11.52

Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA (2007) 11.50

New equations to estimate GFR in children with CKD. J Am Soc Nephrol (2009) 11.48

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA (1995) 11.45

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2004) 11.41

Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA (2007) 10.99

Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care (2008) 10.90

Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37

Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.02

Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA (2004) 9.99

Youth risk behavior surveillance - United States, 2009. MMWR Surveill Summ (2010) 9.63

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56

Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA (2004) 9.55

Reducing children's television viewing to prevent obesity: a randomized controlled trial. JAMA (1999) 9.46

State of disparities in cardiovascular health in the United States. Circulation (2005) 9.32

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 9.27

Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09

Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05

Youth risk behavior surveillance--United States, 2007. MMWR Surveill Summ (2008) 9.04

Burden of valvular heart diseases: a population-based study. Lancet (2006) 8.94

Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA (2010) 8.90

Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med (2005) 8.86

Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA (2001) 8.80

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80

Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med (2010) 8.70

Incidence of diabetes in youth in the United States. JAMA (2007) 8.70

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation (2005) 8.54

Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49

Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43

Effects of care coordination on hospitalization, quality of care, and health care expenditures among Medicare beneficiaries: 15 randomized trials. JAMA (2009) 8.31

Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med (2010) 8.28

Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26

Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation (2006) 8.18

Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med (1999) 8.14

Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA (2005) 8.07

Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1999) 7.93

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol (2007) 7.79

Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75